Related Experiment Video
Updated: Dec 11, 2025

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
Published on: June 3, 2020
Progressive brain atrophy and clinical evolution in Parkinson's disease
Massimo Filippi1, Elisabetta Sarasso2, Noemi Piramide2
1Neuroimaging Research Unit, Institute of Experimental Neurology, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy; Neurology and Neurophysiology Units, IRCCS San Raffaele Scientific Institute, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy.
Brain atrophy, including cortical thinning and subcortical loss, progresses differently in Parkinson's disease (PD) subtypes. Structural MRI can track and predict motor, cognitive, and mood decline in PD patients.
Area of Science:
- Neuroscience
- Neurology
- Radiology
Background:
- Parkinson's disease (PD) exhibits heterogeneous clinical progression.
- Understanding brain structure changes is crucial for predicting PD evolution.
Purpose of the Study:
- To investigate progressive brain atrophy patterns in PD based on disease stage.
- To correlate cortical thinning and subcortical atrophy with clinical motor and non-motor symptom progression.
Main Methods:
- 154 PD patients underwent longitudinal motor, non-motor, and structural MRI over 4 years.
- Cluster analysis identified clinical subtypes; MRI assessed atrophy.
- Brain atrophy progression was compared across subtypes and correlated with clinical outcomes.
Main Results:
- Two main PD clusters emerged: mild (N=87) and moderate-to-severe (N=67).
- Mild PD further divided into motor-predominant and diffuse subtypes, with the latter showing earlier cognitive/non-motor issues.
- Mild-diffuse PD patients exhibited greater cortical and hippocampal atrophy progression; baseline atrophy predicted long-term symptom worsening.
Conclusions:
- Brain atrophy accelerates early in PD, with distinct patterns related to clinical subtypes.
- Structural MRI is a valuable tool for monitoring and predicting PD progression, including motor, cognitive, and mood deficits.
Related Concept Videos
Parkinson's Disease: Overview
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Neural Regulation
Alzheimer's Disease: Treatment

